HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Bon usage des médicaments utilisés dans les formes très actives de sclérose en plaques récurrente », ci-jointe, est adoptée.
See also
Évaluation des médicaments
08/10/2019
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
3wpWTJ5S0jGuBMPr
